Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Health Disparities Subcommittee (HDS), 17410-17411 [2013-06431]
Download as PDF
<![CDATA[
17410
Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices
Proposed Project
Prevention Research Centers Program
National Evaluation Reporting System—
Revision—Division of Population
Health, National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Prevention Research Centers
(PRC) Program was established by
Congress through the Health Promotion
and Disease Prevention Amendments of
1984. PRCs conduct outcomes-oriented
health promotion and disease
prevention research on a broad range of
topics using a multi-disciplinary and
community-based approach. CDC
manages the PRC Program and currently
provides funding to PRC grantees that
are housed within schools of public
health, medicine or osteopathy. Awards
are made for five years and may be
renewed through a competitive
application process.
CDC is currently approved to collect
performance information from PRCs
through a web-based survey and
telephone interview (OMB #0920–0650,
exp. 6/30/2013). The web-based survey
is designed to collect information on the
PRCs’ collaborations with health
departments; formal training programs
and other training activities; and other
funded prevention research projects
conducted separately from their core
research. A structured telephone
interview with a key PRC informant
obtains information on systems and
environmental changes in which PRCs
are involved. The content of the
information collection is guided by a set
of performance indicators developed
(2002) and later revised (2009) in
collaboration with the PRCs.
CDC requests OMB approval to
continue conducting the annual webbased survey and the annual interview.
Changes to be implemented include (1)
changing the platform of the web-based
survey, (2) reducing the number of
questions asked on each instrument,
and (3) revising some questions for
clarity or to reflect the current needs
and priorities of the program. The
proposed changes will result in a net
decrease in burden to respondents.
OMB approval is requested for a
three-year period with a start date of
June 1, 2013. There are no costs to
respondents other than their time. The
total estimated burden hours are 204.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
Form name
PRC Program .........................................
Survey ...................................................
Telephone Interview ..............................
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director.
[FR Doc. 2013–06493 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK67QTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Initial review
The meeting announced below
concerns Epi-Centers for the Prevention
of Healthcare-Associated Infections,
Antimicrobial Resistance and Adverse
Events, Funding Opportunity
Announcement (FOA) CK11–
0010301SUPP13, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
15:09 Mar 20, 2013
Jkt 229001
37
37
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Epi-Centers for the Prevention
of Healthcare-Associated Infections,
Antimicrobial Resistance and Adverse
Events, FOA CK11–0010301SUPP13’’.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06436 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
Time and Date: 1:00 p.m.–4:00 p.m., May
8, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
VerDate Mar<14>2013
PO 00000
Frm 00062
Fmt 4703
Number of
responses per
respondent
Number of
respondents
Sfmt 4703
Average burden
per response
(in hours)
1
1
5
0.5
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 9:00 a.m.–4:45 p.m. EDT,
April 24, 2013.
Place: CDC, Building 19, Rooms 245 and
246, 1600 Clifton Road NE., Atlanta, Georgia
30333.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 20 people. The
public is welcome to participate during the
public comment, which is tentatively
scheduled from 4:30 to 4:40 p.m. This
meeting is also available by teleconference.
Please dial (877) 496–4855 and enter code
4363556.
Purpose: The Subcommittee will provide
advice to the CDC Director through the ACD
on strategic and other health disparities and
health equity issues and provide guidance on
opportunities for CDC.
Matters To Be Discussed: The Health
Disparities Subcommittee members will
discuss CDC’s health equity work in the
environmental health and developmental
E:\FR\FM\21MRN1.SGM
21MRN1
Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices
disabilities areas, as well as discuss health
equity recommendations to the CDC ACD.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K–77, Atlanta, Georgia 30333
Telephone (770) 488–8200, Email:
LEL1@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
Telephone: (404) 639–4461.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06433 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
[FR Doc. 2013–06431 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
Board of Scientific Counselors,
National Center for Health Statistics
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee:
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
emcdonald on DSK67QTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 2:00 p.m.–3:00 p.m., April
18, 2013.
Place: Teleconference.
Status: The meeting is open to the public;
the toll free dial in number is 1–877–951–
7311 with a pass code of 6420598.
Purpose: The BSC, OID, provides advice
and guidance to the Secretary, Department of
Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of
the National Center for Immunization and
Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases,
and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in
the following areas: strategies, goals, and
priorities for programs; research within the
national centers; and overall strategic
direction and focus of OID and the national
centers.
Matters To Be Discussed: The purpose of
the meeting is to discuss the potential for
forming an infectious disease laboratory
working group under the BSC, OID.
The agenda and any supplemental material
will be available at www.cdc.gov/oid/
BSC.html after April 1.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated Federal
VerDate Mar<14>2013
15:09 Mar 20, 2013
Jkt 229001
Times and Dates: 11:00 a.m.–5:30 p.m.,
May 6, 2013, 8:30 a.m.–1:00 p.m., May 7,
2013
Place: NCHS Headquarters, 3311 Toledo
Road, Hyattsville, Maryland 20782.
Status: This meeting is open to the public;
however, visitors must be processed in
accordance with established federal policies
and procedures. For foreign nationals or nonUS citizens, pre-approval is required (please
contact Althelia Harris, 301–458–4261,
adw1@cdc.gov or Virginia Cain,
vcain@cdc.gov at least 10 days in advance for
requirements). All visitors are required to
present a valid form of picture identification
issued by a state, federal or international
government. As required by the Federal
Property Management Regulations, Title 41,
Code of Federal Regulation, Subpart 101–
20.301, all persons entering in or on Federal
controlled property and their packages,
briefcases, and other containers in their
immediate possession are subject to being xrayed and inspected. Federal law prohibits
the knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal substances.
The meeting room accommodates
approximately 100 people.
Purpose: This committee is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human Services;
the Director, CDC; and the Director, NCHS,
regarding the scientific and technical
program goals and objectives, strategies, and
priorities of NCHS.
Matters To Be Discussed: The agenda will
include welcome remarks by the Acting
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
17411
Director, NCHS; the February 5, 2013 ORM
Program Review; discussion of revisions to
the program review protocol; program
updates.
Requests to make oral presentations should
be submitted in writing to the contact person
listed below. All requests must contain the
name, address, telephone number, and
organizational affiliation of the presenter.
Written comments should not exceed five
single-spaced typed pages in length and must
be received by April 22, 2013.
The agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7208, Hyattsville,
Maryland 20782, telephone (301) 458–4500,
fax (301) 458–4020.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06432 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Monitoring and Evaluation of
Malaria Control and Elimination
Activities, FOA GH13–005, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–3:00 p.m., May
21, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Monitoring and Evaluation of
Malaria Control and Elimination Activities,
FOA GH13–005, initial review.’’
Contact Person for More Information:
Hylan D. Shoob, Ph.D., M.S.P.H., Scientific
E:\FR\FM\21MRN1.SGM
21MRN1
]]>Agencies
[Federal Register Volume 78, Number 55 (Thursday, March 21, 2013)]
[Notices]
[Pages 17410-17411]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06431]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--Health Disparities Subcommittee (HDS)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 9:00 a.m.-4:45 p.m. EDT, April 24, 2013.
Place: CDC, Building 19, Rooms 245 and 246, 1600 Clifton Road
NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 20 people. The public is
welcome to participate during the public comment, which is
tentatively scheduled from 4:30 to 4:40 p.m. This meeting is also
available by teleconference. Please dial (877) 496-4855 and enter
code 4363556.
Purpose: The Subcommittee will provide advice to the CDC
Director through the ACD on strategic and other health disparities
and health equity issues and provide guidance on opportunities for
CDC.
Matters To Be Discussed: The Health Disparities Subcommittee
members will discuss CDC's health equity work in the environmental
health and developmental
[[Page 17411]]
disabilities areas, as well as discuss health equity recommendations
to the CDC ACD.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Leandris Liburd, Ph.D.,
M.P.H., M.A., Designated Federal Officer, Health Disparities
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K-77, Atlanta, Georgia 30333 Telephone (770) 488-8200,
Email: LEL1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2013-06431 Filed 3-20-13; 8:45 am]
BILLING CODE 4163-18-P
